Provided are compounds which can be used in combination for treating diseases associated with a condition associated with cerebral accumulation of Alzheimer's amyloid, such as Alzheimer's disease. Also provided are methods of treating or reducing the risk of developing β-amyloid production, β-amyloid deposition, β-amyloid neurotoxicity (including abnormal hyperphosphorylation of tau) and microgliosis associated with cerebral accumulation of Alzheimer's amyloid by administering therapeutically effective amounts of compounds which in combination can decrease β-amyloid production and capacitative calcium entry in cells. Further provided are methods for diagnosing diseases associated with cerebral accumulation of Alzheimer's amyloid in animals or humans by administering diagnostically effective amounts of the compounds.
提供了一些化合物,可以组合使用来治疗与阿尔茨海默病淀粉样蛋白相关的疾病,如阿尔茨海默病。还提供了一种方法,通过给予治疗有效量的化合物组合来减少β-淀粉样蛋白的产生和细胞中的电容性
钙离子进入,从而治疗或降低发生β-淀粉样蛋白产生、β-淀粉样蛋白沉积、β-淀粉样蛋白神经毒性(包括tau异常过度
磷酸化)和与阿尔茨海默病淀粉样蛋白相关的微胶质病变。此外,还提供了一种方法,通过给予诊断有效量的化合物来诊断动物或人类中与阿尔茨海默病淀粉样蛋白相关的疾病。